SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-023867
Filing Date
2018-04-30
Accepted
2018-04-30 16:18:31
Documents
13
Period of Report
2018-06-14
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv492070-def14a.htm DEF 14A 1113194
2 GRAPHIC lg_novavax-today.jpg GRAPHIC 65313
3 GRAPHIC lg_novavax.jpg GRAPHIC 46623
4 GRAPHIC ph_garyc-evans.jpg GRAPHIC 45842
5 GRAPHIC ph_jamesf-young.jpg GRAPHIC 39849
6 GRAPHIC ph_michaela-mcmanus.jpg GRAPHIC 40361
7 GRAPHIC ph_rajivi-modi.jpg GRAPHIC 48093
8 GRAPHIC ph_richardh-douglas.jpg GRAPHIC 42296
9 GRAPHIC ph_stanleyc-erck.jpg GRAPHIC 38419
10 GRAPHIC sg_john-herrmann3.jpg GRAPHIC 16090
11 GRAPHIC sg_stanley-erck.jpg GRAPHIC 28262
12 GRAPHIC tv492070_prycrd1.jpg GRAPHIC 617457
13 GRAPHIC tv492070_prycrd2.jpg GRAPHIC 523693
  Complete submission text file 0001144204-18-023867.txt   3252510
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 18790024
SIC: 2836 Biological Products, (No Diagnostic Substances)